Hormone Therapy News

Throughout human history, there have been people who were transgender, individuals whose gender identity and expression differ from the sex they appear to be at birth. Some cultures accepted these differences, whereas others violently opposed them. The current world culture is in the midst of a sea change with regard to gender. And although there is still open hostility in some sectors, in many places, there is an increased openness toward people who are gender-nonconforming.

Several health factors identified by researchers as significant predictors of testosterone deficiency have been folded into a simplified tool that physicians may use for screening purposes, according to an article in the Journal of Men’s Health.

Whether low levels of vitamin D play a role in menopause-related symptoms still remains to be proven, according to research published online in Menopause.

Three recently published studies examined the protective effects of estrogen in older men and women.

The use of clomiphene citrate or gonadotropins as a part of fertility treatment did not increase the risk for breast cancer, according to long-term study results.

In women with low testosterone levels, a short-term regimen of testosterone treatment over a wide range of doses did not appear to increase cardiovascular risk, according to findings from the Testosterone Dose Response in Surgically Menopausal Women trial.

A reduction in plasma triglyceride concentrations was observed in postmenopausal women after estradiol treatment but not progesterone or testosterone, according to research in The Journal of Clinical Endocrinology & Metabolism, shedding light on the sexual dimorphism in metabolizing the cholesterol component.

In postmenopausal women considered at risk for dementia, continued treatment with 17-beta-estradiol hormone therapy is associated with the preservation of regional cerebral cortical metabolism for at least 2 years, according to recent findings.

SAN DIEGO — Physical activity, even of moderate intensity, was associated with a 20% to 30% decreased risk for stroke in women, according to data presented at the International Stroke Conference.

Research suggests that 2 years of growth hormone therapy in adults with Prader-Willi syndrome improved body composition, muscle size and quality, and increased muscle strength and exercise tolerance independently from the growth hormone secretory status.